VARIABLES

Demographics

(264 = 100%)

Latissimus Dorsi (18 = 6.8%)

TRAM Flap (84 = 31.8%)

Tissue Expander (138 = 52.2%)

Direct-to-implant (24 = 9.09%)

Type of breast cancer

Invasive ductal carcinoma (n/%)

228 (86.3%)

18 (100%)

6 (7.14%)

6 (4.5%)

6 (20%)

Ductal carcinoma in situ (n/%)

16 (6.06%)

0

66 (78.57%)

126 (95.5%)

10 (33.3%)

Invasive lobular carcinoma (n/%)

14 (5.03%)

0

6 (7.14%)

0

8 (26.66%)

Lobular carcinoma in situ (n/%)

6 (2.2%)

0

6 (7.14%)

0

6 (20%)

Receptor

Estrogen receptor positive (n/%)

186 (70.45%)

12 (66.6%)

54 (64.2%)

102 (77.2%)

12 (50%)

Estrogen receptor negative (n/%)

78 (29.55%)

6 (33.4%)

30 (35.8%)

30 (22.8%)

12 (50%)

Progesterone receptors positive (n/%)

162 (61.3%)

6 (33.3%)

54 (64.2%)

96 (72.7%)

6 (25%)

Progesterone receptors negative (n/%)

102 (38.6%)

12 (66.6%)

30 (35.7%)

42 (27.3%)

18 (75%)

HER2-positive (n/%)

144 (54.5%)

6 (33.3%)

36 (42.8%)

96 (72.7%)

6 (25%)

HER2-negative (n/%)

120 (45.4%)

12 (66.6%)

48 (57.1%)

42 (27.3%)

18 (75%)

Laterality

Right (n/%)

138 (52.2%)

12 (66.6%)

0

66 (50%)

18 (75%)

Left (n/%)

108 (40.9%)

6 (33.3%)

42 (50%)

54 (40.9%)

6 (25%)

Bilateral (n/%)

18 (6.8%)

0

42 (50%)

12 (9.09%)

0